In 2010, revised guidelines outlined eligibility for ART among persons with TB/HIV to include those with CD4 cell count ≤ 350 cells/mm3 and those with multidrug-resistant or extensively drug-resistant TB (MDR-TB or XDR-TB), irrespective of CD4 cell count [4]. This evidence concerns the gene CD4 and tuberculosis.